Platinum resistance in breast and ovarian cancer cell lines
about
Use of poly ADP-ribose polymerase [PARP] inhibitors in cancer cells bearing DDR defects: the rationale for their inclusion in the clinicIdentifying differential networks based on multi-platform gene expression data.The multiple facets of drug resistance: one history, different approaches.Epithelial-mesenchymal transition spectrum quantification and its efficacy in deciphering survival and drug responses of cancer patients.Eradication of Human Ovarian Cancer Cells by Transgenic Expression of Recombinant DNASE1, DNASE1L3, DNASE2, and DFFB Controlled by EGFR Promoter: Novel Strategy for Targeted Therapy of Cancer.Dissecting the role of curcumin in tumour growth and angiogenesis in mouse model of human breast cancerA metabolomic approach to identifying platinum resistance in ovarian cancer.Inhibitory effect of baicalin and baicalein on ovarian cancer cells.Proteasome Inhibitor YSY01A Enhances Cisplatin Cytotoxicity in Cisplatin-Resistant Human Ovarian Cancer Cells.Gemcitabine-oxaliplatin (GEMOX) as salvage treatment in pretreated epithelial ovarian cancer patients.Antisense oligonucleotide suppression of human IGF-1R inhibits the growth and survival of in vitro cultured epithelial ovarian cancer cells.Clinical pharmacology of tyrosine kinase inhibitors becoming generic drugs: the regulatory perspectiveSequential application of a cytotoxic nanoparticle and a PI3K inhibitor enhances antitumor efficacy.Catching moving targets: cancer stem cell hierarchies, therapy-resistance & considerations for clinical intervention.Antiproliferative effects of ruthenium-based nucleolipidic nanoaggregates in human models of breast cancer in vitro: insights into their mode of action.Potential nanotechnologies and molecular targets in the quest for efficient chemotherapy in ovarian cancer.Modulators of the human ABCC2: hope from natural sources?Metabolomics applications in precision medicine: An oncological perspective.Structure Effect of Some New Anticancer Pt(II) Complexes of Amino Acid Derivatives with Small Branched or Linear Hydrocarbon Chains on Their DNA Interaction.Polymer nanoparticle delivery of dichloroacetate and DACH-Pt to enhance antitumor efficacy and lower systemic toxicity.Overcoming tumor resistance to cisplatin through micelle-mediated combination chemotherapy.Effect of photodynamic therapy with hypocrellin B on apoptosis, adhesion, and migration of cancer cells.Contribution of reactive oxygen species to ovarian cancer cell growth arrest and killing by the anti-malarial drug artesunate.STAT3 but Not HIF-1α Is Important in Mediating Hypoxia-Induced Chemoresistance in MDA-MB-231, a Triple Negative Breast Cancer Cell Line.Applications of functionalized nanomaterials in photodynamic therapy.Targeting BRCA1/2 deficient ovarian cancer with CNDAC-based drug combinations.Comparisons of gene coexpression network modules in breast cancer and ovarian cancer.
P2860
Q28071541-9B7699FF-CE3D-4E37-9BB6-F1ACDE1C7058Q31143551-16B745D8-CD6C-4F10-AFB2-AC7AC76C6730Q33697116-C0899BC2-1F17-4308-9274-F8EABA8DAE75Q34880376-22ADA74B-1A37-48C7-AFF2-A54E2311DF9BQ35109273-41F10CB7-5CD4-4A40-8B02-DDFCF1729671Q35281792-86F5AAB0-7B61-4C3E-A6E7-1312C5EBB730Q35404082-96C739AE-D579-4217-BB0D-F72253BF2BFAQ36790496-4C95ED06-3721-436C-A610-103D9F6CA3EFQ37015742-56829D77-9F96-48E1-964A-A78AA88B0672Q37113732-3B29C25C-26D6-4852-99A9-D8D788DF0B5EQ37365005-F477EB3C-EC79-4E32-952E-8734D4B77878Q37580148-4F505B01-0A83-4F10-9CF7-A5386786ECEBQ37624426-8D4D8A5F-5D59-44C6-96C1-27ACDD391753Q37661508-B0817385-FC66-4454-A181-F9DBE9252829Q37724010-874D504A-8040-4DD2-A299-3C8C5B7FDDF1Q38258602-ED9BA25F-78D3-40D4-A84A-B92438E1F815Q38614964-7C812A54-8A54-486B-B5A8-F6E8051F8054Q38689857-73B7F270-8C25-4CCD-A71A-367E186AA43CQ38797478-AD30F51F-01CC-49DC-8C12-DAFB956A0C0CQ38799444-73A25FD3-ED55-4FA7-B98F-BFD86A206037Q38848959-5BDA9BA0-170D-4729-87FE-AC24C56E789CQ39012505-089E6A92-0551-41AC-B92F-850D173F29EDQ39996069-6F07558A-EF0D-4442-831B-C66083F42413Q43499055-312BC664-6DBE-46BB-8603-1555AC2C8C8EQ47755734-AB388203-B89F-4F63-AC0D-58AF4B85DFB6Q48211870-09D5EF9F-108D-434B-A715-B95CDAB6BAC7Q54956414-C2E704A8-B5E0-4B33-9058-0B71DC8D0DC0
P2860
Platinum resistance in breast and ovarian cancer cell lines
description
2011 nî lūn-bûn
@nan
2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Platinum resistance in breast and ovarian cancer cell lines
@ast
Platinum resistance in breast and ovarian cancer cell lines
@en
type
label
Platinum resistance in breast and ovarian cancer cell lines
@ast
Platinum resistance in breast and ovarian cancer cell lines
@en
prefLabel
Platinum resistance in breast and ovarian cancer cell lines
@ast
Platinum resistance in breast and ovarian cancer cell lines
@en
P2860
P921
P356
P1476
Platinum resistance in breast and ovarian cancer cell lines
@en
P2093
Niels Eckstein
P2860
P2888
P356
10.1186/1756-9966-30-91
P5008
P577
2011-10-04T00:00:00Z
P5875
P6179
1039948368